Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, 4072, Australia.
Department of Molecular Sciences, Australian Research Council Centre of Excellence for Nanoscale BioPhotonics, Faculty of Science and Engineering, Macquarie University, Sydney, NSW, 2109, Australia.
Small. 2019 Dec;15(50):e1904689. doi: 10.1002/smll.201904689. Epub 2019 Nov 13.
The modernized use of nucleic acid (NA) sequences to drive nanostructure self-assembly has given rise to a new class of designed nanomaterials with controllable plasmonic functionalities for broad surface-enhanced Raman scattering (SERS)-based bioanalysis applications. Herein, dual usage of microRNAs (miRNAs) as both valuable cancer biomarkers and direct self-assembly triggers is identified and capitalized upon for custom-designed plasmonic nanostructures. Through strict NA hybridization of miRNA targets, Au nanospheres selectively self-assemble onto hollowed Au/Ag alloy nanocuboids with ideal interparticle distances (≈2.3 nm) for optimal SERS signaling. The intrinsic material properties of the self-assembled nanostructures further elevate miRNA detection performance via nanozyme catalytic SERS signaling cascades. This enables fM-level miR-107 detection limit within a clinically-relevant range without any molecular target amplification. The miRNA-triggered nanostructure self-assembly approach is further applied in clinical patient samples, and showcases the potential of miR-107 as a non-invasive prostate cancer diagnostic biomarker. The use of miRNA targets to drive nanostructure self-assembly holds great promise as a practical tool for miRNA detection in disease applications.
核酸(NA)序列的现代化应用驱动了纳米结构的自组装,产生了一类具有可控等离子体功能的新型设计纳米材料,可广泛应用于基于表面增强拉曼散射(SERS)的生物分析。在此,将 microRNAs(miRNAs)同时用作有价值的癌症生物标志物和直接自组装触发物的双重用途被确定并应用于定制设计的等离子体纳米结构。通过 miRNA 靶标的严格 NA 杂交,金纳米球选择性地自组装到具有理想粒子间距离(≈2.3nm)的中空 Au/Ag 合金纳米立方上,以实现最佳 SERS 信号。自组装纳米结构的固有材料特性通过纳米酶催化 SERS 信号级联进一步提高了 miRNA 的检测性能。这使得能够在无需任何分子靶标扩增的情况下,在临床相关范围内检测到 fM 级别的 miR-107,检测限为 fM 级。该 miRNA 触发的纳米结构自组装方法进一步应用于临床患者样本中,并展示了 miR-107 作为非侵入性前列腺癌诊断生物标志物的潜力。利用 miRNA 靶标来驱动纳米结构的自组装有望成为疾病应用中 miRNA 检测的实用工具。